Global Market for Flexible Manufacturing Systems in the Pharmaceutical Industry

Report Highlights

The global market for flexible manufacturing systems in the pharmaceutical industry should grow from $1.8 billion in 2021 to $2.3 billion by 2026 with a compound annual growth rate (CAGR) of 5.4% for the period of 2021-2026.

Report Includes

• 22 data tables and 20 additional tables
• An overview of the global market for flexible manufacturing systems in the pharmaceutical industry
• Estimation of the market size and analyses of the global market trends, with data from 2019, 2020, estimates for 2021 with projection of CAGR through 2026
• Market share analysis of flexible manufacturing systems based on approaches, industry type, application, and geography, and identification of new opportunities, challenges, and technological changes within the industry
• Detailed description of flexible manufacturing system, its working, objectives, benefits, and limitations
• Detailed analysis of the regulatory framework and policies, reimbursement scenarios and key product and technology developments
• Identification of economic and demographic factors affecting the market growth and market insights about the future of the industry
• Information on quicker approval processes of regulatory authorities for the new drugs, and initiatives by international organizations to improve flexible manufacturing systems
• Market share analysis of the key companies of the industry and coverage of their proprietary technologies, strategic alliances, and other key market strategies
• Company profiles of major players in the market, including Cytiva, Jacobs Engineering Inc., Exyte GmbH, G-CON Manufacturing, KeyPlants AB and Germfree Laboratories Inc.

Report Scope

This report provides a detailed description of flexible manufacturing systems in the pharmaceutical industry and the latest technologies in the market. The report includes market estimates for different types of flexible manufacturing systems and also includes recent technological developments and assessments of product performance in the market.

Based on the approach type, the flexible manufacturing systems in pharmaceutical industry is segmented into modular manufacturing, data-driven manufacturing, single-use manufacturing, and continuous manufacturing.

Based on application, the market is segmented into manufacturing, aseptic filling and others (research and development, clinical research and academic research).

Based on industry, the market is segmented into pharmaceutical and biotechnology.

The report discusses the qualitative and quantitative factors influencing the market growth. The market drivers, restraints and opportunities are discussed in the report.

This report discusses some of the major drivers and restraints as well as the competition and key players’ strategies and performances. The discussion is focused on the major market players, trends in product launches, collaborations, and mergers and acquisitions. The report also emphasizes the company profiles of major vendors including company overview, key product offerings, financial statistics and recent developments. The report also provides insights on the market share and upcoming regional demand.

Some of the major market players discussed in the report are Cytiva, Jacobs Engineering Inc., Exyte GmbH, G-CON Manufacturing, KeyPlants AB and Germfree Laboratories Inc. For market estimates, data have been provided for the year 2019 as the base year, with forecasts for 2021 through 2026. Estimated values used are based on manufacturers’ total revenues. Projected and forecasted revenue values are in constant U.S. dollars, unadjusted for inflation.

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.

• Bioprocess Optimization and Digital Bio-manufacturing: Global Markets (BIO170B)
• Metal-organic Frameworks: Global Markets (AVM200B)
• Laboratory Animal Models, 3D Cultures, and Organoids: Global Markets (PHM204C)
• Global DNA Sequencing: Research, Applied and Clinical Markets (BIO045J)
• Surgical Equipment: Technologies and Global Markets (HLC154C)